Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism

BACKGROUND: Data that guide selection of differing anticoagulant regimens for specific cancer-associated venous thromboembolism (VTE) are lacking. We aimed to compare the efficacy and safety of rivaroxaban and low-molecular-weight heparin (LMWH) against nonhigh-risk pulmonary embolism (PE) in Chines...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yijun, Yang, Dawei, Hou, Dongni, She, Jun, Song, Yuanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893535/
https://www.ncbi.nlm.nih.gov/pubmed/36732741
http://dx.doi.org/10.1186/s12959-023-00453-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893535/
https://www.ncbi.nlm.nih.gov/pubmed/36732741
http://dx.doi.org/10.1186/s12959-023-00453-y

Ejemplares similares